• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

评价β1-选择性β受体阻滞剂对绝经后妇女骨密度和骨折风险的影响。

Evaluation of the effects of β1-selective beta-blockers on bone mineral density and fracture risk in postmenopausal women.

机构信息

İstanbul Physical Medicine and Rehabilitation Training and Research Hospital, İstanbul, Turkey

Bakırköy Dr. Sadi Konuk Training Hospital, İstanbul, Turkey

出版信息

Turk J Med Sci. 2020 Jun 23;50(4):994-998. doi: 10.3906/sag-1909-187.

DOI:10.3906/sag-1909-187
PMID:32283907
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7379456/
Abstract

BACKGROUND/AIM: β1-selective beta-blockers (BBs) are sympatholytic agents, and discerning their effects on bone health would be of great importance. This study aimed to investigate the influence of β1-selective BBs on bone mineral density (BMD) and fracture risk.

MATERIALS AND METHODS

This study included postmenopausal women who used β1-selective BBs (BB group) and control group. Sociodemographic characteristics, BMD and previous fragility fractures were recorded. Additionally, the 10-year probability of a major osteoporotic and hip fracture was calculated using the fracture risk assessment tool (FRAX).

RESULTS

A total of 60 participants were included in the study. L1-4 and L2-4 BMD values were significantly higher in BB group than control group (P = 0.015 and P = 0.025, respectively). Moreover, T-scores of lumbar and femur total were significantly higher in the BB group. Two patients in BB and 6 patients in control group had previous fragility fracture. No statistically significant intergroup difference was noted regarding FRAX.

CONCLUSION

Based on our results, β1-selective BB usage was associated with higher BMD at the lumbar region in postmenopausal women.

摘要

背景/目的:β1 选择性β受体阻滞剂(BB)是一种拟交感神经药物,了解它们对骨骼健康的影响非常重要。本研究旨在探讨β1 选择性 BB 对骨密度(BMD)和骨折风险的影响。

材料和方法

本研究纳入了使用β1 选择性 BB 的绝经后女性(BB 组)和对照组。记录了社会人口统计学特征、BMD 和既往脆性骨折情况。此外,使用骨折风险评估工具(FRAX)计算了 10 年内发生主要骨质疏松性骨折和髋部骨折的概率。

结果

本研究共纳入 60 名参与者。与对照组相比,BB 组的 L1-4 和 L2-4 BMD 值显著更高(P = 0.015 和 P = 0.025)。此外,BB 组的腰椎和股骨总 T 评分也显著更高。BB 组有 2 名患者和对照组有 6 名患者有既往脆性骨折。FRAX 两组间无统计学显著差异。

结论

根据我们的结果,β1 选择性 BB 使用与绝经后女性腰椎区域更高的 BMD 相关。

相似文献

1
Evaluation of the effects of β1-selective beta-blockers on bone mineral density and fracture risk in postmenopausal women.评价β1-选择性β受体阻滞剂对绝经后妇女骨密度和骨折风险的影响。
Turk J Med Sci. 2020 Jun 23;50(4):994-998. doi: 10.3906/sag-1909-187.
2
Effect of abaloparatide on vertebral, nonvertebral, major osteoporotic, and clinical fractures in a subset of postmenopausal women at increased risk of fracture by FRAX probability.依发洛肽对 FRAX 概率评估骨折风险增高的绝经后妇女亚组的椎体、非椎体、主要骨质疏松性和临床骨折的影响。
Arch Osteoporos. 2019 Feb 5;14(1):15. doi: 10.1007/s11657-019-0564-7.
3
Which is the preferred site for bone mineral density monitoring as an indicator of treatment-related anti-fracture effect in routine clinical practice? A registry-based cohort study.在常规临床实践中,作为治疗相关抗骨折效果的指标,监测骨密度的首选部位是哪里?一项基于登记的队列研究。
Osteoporos Int. 2019 Jul;30(7):1445-1453. doi: 10.1007/s00198-019-04975-y. Epub 2019 Apr 23.
4
Fracture Risk Assessment Tool (FRAX®) Results Calculated With and Without Bone Mineral Density Values for the Evaluation of Fracture Risk in Postmenopausal Women With Osteopenia.基于骨密度值和不基于骨密度值的骨折风险评估工具(FRAX®)结果计算在骨质疏松症绝经后妇女中评估骨折风险。
J Clin Densitom. 2018 Oct-Dec;21(4):464-471. doi: 10.1016/j.jocd.2017.06.027. Epub 2017 Aug 3.
5
Correlation between osteoporotic fracture risk in Brazilian postmenopausal women calculated using the FRAX with and without the inclusion of bone densitometry data.在巴西绝经后女性中,使用FRAX计算的骨质疏松性骨折风险在纳入和未纳入骨密度测量数据时的相关性。
Arch Osteoporos. 2016;11:16. doi: 10.1007/s11657-015-0255-y. Epub 2016 Apr 11.
6
Influence of bone mineral density measurement on fracture risk assessment tool® scores in postmenopausal Indian women.骨密度测量对绝经后印度女性骨折风险评估工具®评分的影响。
Post Reprod Health. 2016 Mar;22(1):20-4. doi: 10.1177/2053369116628722. Epub 2016 Jan 28.
7
FRAX® based intervention thresholds for management of osteoporosis in Singaporean women.基于 FRAX 的新加坡女性骨质疏松症管理干预阈值。
Arch Osteoporos. 2018 Nov 19;13(1):130. doi: 10.1007/s11657-018-0542-5.
8
Serial Bone Density Measurement and Incident Fracture Risk Discrimination in Postmenopausal Women.绝经后妇女的骨密度连续测量与骨折风险的鉴别。
JAMA Intern Med. 2020 Sep 1;180(9):1232-1240. doi: 10.1001/jamainternmed.2020.2986.
9
β-Adrenergic receptor antagonists and fracture risk: a meta-analysis of selectivity, gender, and site-specific effects.β-肾上腺素能受体拮抗剂与骨折风险:选择性、性别和部位特异性影响的荟萃分析。
Osteoporos Int. 2014 Jan;25(1):121-9. doi: 10.1007/s00198-013-2498-z. Epub 2013 Oct 10.
10
Setting the new FRAX reference threshold without bone mineral density in Chinese postmenopausal women.在中国绝经后妇女中设定新的 FRAX 参考阈值而不考虑骨密度。
J Endocrinol Invest. 2021 Feb;44(2):347-352. doi: 10.1007/s40618-020-01315-4. Epub 2020 Jun 3.

引用本文的文献

1
Impact of Medications for Stable Angina Pectoris on Osteoporosis: A Review of Current Evidence.稳定型心绞痛药物对骨质疏松症的影响:当前证据综述
J Multidiscip Healthc. 2025 Jul 19;18:4121-4131. doi: 10.2147/JMDH.S526091. eCollection 2025.
2
Atenolol, alone or in combination with PTH, has a modest effect on bone in female C57BL/6J mice.阿替洛尔单独使用或与甲状旁腺激素联合使用时,对雌性C57BL/6J小鼠的骨骼有一定影响。
JBMR Plus. 2025 May 15;9(7):ziaf087. doi: 10.1093/jbmrpl/ziaf087. eCollection 2025 Jul.
3
Repurposing Acebutolol for Osteoporosis Treatment: Insights From Multi-Omics and Multi-Modal Data Analysis.将醋丁洛尔重新用于骨质疏松症治疗:多组学和多模态数据分析的见解
Clin Pharmacol Ther. 2025 Jun 6. doi: 10.1002/cpt.3738.
4
Effects of Selective and Nonselective Beta Blockers on Bone Mineral Density in Mexican Patients with Breast Cancer.选择性和非选择性β受体阻滞剂对墨西哥乳腺癌患者骨密度的影响。
Cancers (Basel). 2024 Aug 20;16(16):2891. doi: 10.3390/cancers16162891.
5
Regulation of bone metabolism mediated by β-adrenergic receptor and its clinical application.β-肾上腺素能受体介导的骨代谢调节及其临床应用
World J Clin Cases. 2021 Oct 26;9(30):8967-8973. doi: 10.12998/wjcc.v9.i30.8967.

本文引用的文献

1
Osteoporosis in postmenopausal women in this decade: a bibliometric assessment of current research and future hotspots.绝经后妇女骨质疏松症在这十年中:当前研究和未来热点的文献计量评估。
Arch Osteoporos. 2018 Nov 7;13(1):121. doi: 10.1007/s11657-018-0534-5.
2
Sympathetic β1-adrenergic signaling contributes to regulation of human bone metabolism.交感β1-肾上腺素能信号有助于调节人类骨代谢。
J Clin Invest. 2018 Nov 1;128(11):4832-4842. doi: 10.1172/JCI122151. Epub 2018 Oct 2.
3
Prevalence and comorbidity of osteoporosis- a cross-sectional analysis on 10,660 adults aged 50 years and older in Germany.骨质疏松症的患病率及共病情况——对德国10660名50岁及以上成年人的横断面分析
BMC Musculoskelet Disord. 2018 May 14;19(1):144. doi: 10.1186/s12891-018-2060-4.
4
Inverse association between sympathetic nervous system activity and bone mass in middle aged overweight individuals.中年超重人群中交感神经系统活动与骨量呈负相关。
Bone. 2018 Jun;111:123-128. doi: 10.1016/j.bone.2018.03.025. Epub 2018 Mar 29.
5
The Impact of Antihypertensive Medications on Bone Mineral Density and Fracture Risk.抗高血压药物对骨密度和骨折风险的影响。
Curr Cardiol Rep. 2017 Sep;19(9):76. doi: 10.1007/s11886-017-0888-0.
6
Osteogenic actions of metoprolol in an ovariectomized rat model of menopause.美托洛尔在去卵巢大鼠绝经模型中的成骨作用
Menopause. 2016 Sep;23(9):1019-25. doi: 10.1097/GME.0000000000000680.
7
Drugs that may harm bone: Mitigating the risk.可能损害骨骼的药物:降低风险。
Cleve Clin J Med. 2016 Apr;83(4):281-8. doi: 10.3949/ccjm.83a.15066.
8
Clinical Practice. Postmenopausal Osteoporosis.临床实践。绝经后骨质疏松症。
N Engl J Med. 2016 Jan 21;374(3):254-62. doi: 10.1056/NEJMcp1513724.
9
Bone mineral density changes among women initiating blood pressure lowering drugs: a SWAN cohort study.开始使用降压药物的女性骨矿物质密度变化:一项SWAN队列研究。
Osteoporos Int. 2016 Mar;27(3):1181-1189. doi: 10.1007/s00198-015-3332-6. Epub 2015 Oct 8.
10
Insights into the epidemiology of postmenopausal osteoporosis: the Women's Health Initiative.绝经后骨质疏松症流行病学洞察:妇女健康倡议研究
Semin Reprod Med. 2014 Nov;32(6):454-62. doi: 10.1055/s-0034-1384629. Epub 2014 Oct 16.